Ari Zweiman
@683 Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$1.315BTotal holdings139
Assets growth rate-0.62%Assets growth rate (2-Q avg)-1.9%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in 683 Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 139 positions.
Assets under management
The assets under management (AUM) of 683 Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.315B in assets, with a quarterly growth rate of -0.62% and a 2-quarter average growth rate of -1.9%. The portfolio is managed by Ari Zweiman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PDDPdd Holdings Inc
| 0.92% | $11.998M 89,000 shares@ $134.81 avg price | New Position |
BMRNBiomarin Pharmaceutical Inc
| 0.82% | $10.754M 153,000 shares@ $70.29 avg price | New Position |
LENLennar Corp
| 0.65% | $8.437M↓ Put 45,000 shares@ $187.48 avg price | New Position |
NENoble Corp Plc
| 0.46% | $6.04M 167,118 shares@ $36.15 avg price | New Position |
ASMLAsml Holding N V
| 0.32% | $4.166M 5,000 shares@ $833.25 avg price | New Position |
HCCWarrior Met Coal Inc
| 0.27% | $3.514M 55,000 shares@ $63.9 avg price | New Position |
STGWStagwell Inc
| 0.21% | $2.703M 385,000 shares@ $7.02 avg price | New Position |
SVMSilvercorp Metals Inc
| 0.2% | $2.622M 600,000 shares@ $4.37 avg price | New Position |
PYXSPyxis Oncology Inc
| 0.12% | $1.522M 414,656 shares@ $3.68 avg price | New Position |
RNACCartesian Therapeutics Inc
| 0.1% | $1.216M 75,431 shares@ $16.13 avg price | New Position |